Global Stock News

SQI Diagnostics Inc. Responds to Change in FDA Priorities in Emergency Use Authorization

Article feature image

SQI Diagnostics Inc. Responds to Change in FDA Priorities in Emergency Use Authorization

TORONTO, Oct. 19, 2021 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics,…

Click here to view the original article.

Share this article

Scroll to Top